Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Dehm

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
European Urology|August 7, 2025
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate CancerSusan Halabi, Siyuan Guo, Bin Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
Diverse <i>AR</i> Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate CancerYingming Li, Rendong Yang, Christine M Henzler, et al.
Cancer Discovery|July 25, 2025
Off-pore nucleoporin sPOM121 transcriptionally propels β-Catenin driven tumor progression and immune escape in prostate cancerPerumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li, et al.
Cell Reports. Medicine|April 21, 2026
Plasma extracellular vesicle proteomics nominates candidate biomarkers of <sup>177</sup>Lu-PSMA-617 outcomes in metastatic prostate cancer patientsAli T Arafa, Ella Boytim, Megan L Ludwig, et al.
Oncotarget|November 12, 2015
Expression of androgen receptor splice variants in clinical breast cancersTheresa E Hickey, Connie M Irvine, Heidi Dvinge, et al.
Oncogene|February 12, 2019
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategyVaradha Balaji Venkadakrishnan, Adam D DePriest, Sangeeta Kumari, et al.
Plos One|December 24, 2015
Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide TherapyManish Kohli, Liguo Wang, Fang Xie, et al.
Oncotarget|April 9, 2026
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancerAllison Makovec, John T Phoenix, Hannah E Bergom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic SubtypesJustin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
European Urology|August 7, 2025
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate CancerSusan Halabi, Siyuan Guo, Bin Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
Diverse <i>AR</i> Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate CancerYingming Li, Rendong Yang, Christine M Henzler, et al.
Cancer Discovery|July 25, 2025
Off-pore nucleoporin sPOM121 transcriptionally propels β-Catenin driven tumor progression and immune escape in prostate cancerPerumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li, et al.
Cell Reports. Medicine|April 21, 2026
Plasma extracellular vesicle proteomics nominates candidate biomarkers of <sup>177</sup>Lu-PSMA-617 outcomes in metastatic prostate cancer patientsAli T Arafa, Ella Boytim, Megan L Ludwig, et al.
Oncotarget|November 12, 2015
Expression of androgen receptor splice variants in clinical breast cancersTheresa E Hickey, Connie M Irvine, Heidi Dvinge, et al.
Oncogene|February 12, 2019
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategyVaradha Balaji Venkadakrishnan, Adam D DePriest, Sangeeta Kumari, et al.
Plos One|December 24, 2015
Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide TherapyManish Kohli, Liguo Wang, Fang Xie, et al.
Oncotarget|April 9, 2026
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancerAllison Makovec, John T Phoenix, Hannah E Bergom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic SubtypesJustin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.
Pageof 13